Renalytix Plc

NASDAQ
RNLX
paper.types.company
Rentabilité sur six mois: 0%
Rendement en dividendes: 0%
Secteur: Healthcare

0.142 $

0 $ 0%
0.1321 $
0.45 $

paper.min_max_per_year

Calendrier des promotions Renalytix Plc

Calendrier avancé Graphique simple
Financial Markets by TradingView
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2020-07-17
ISIN
US75973T1016
Industry
Health Care Technology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 16.65 1
P/BV -4.85 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA -133.59 0
ROE -631.25 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.2993 10
Debt/Ratio 1.07 8
Debt/Equity -2.02 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 52.6 7
Rentabilité Ebitda, % 156.95 10
Rentabilité EPS, % -1.23 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.142 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.142 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 0.142 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.90d 0.142 $ 0.142 $ 0.142 $ 0 % 0 % 0 %
common.calendar.number_days.180d 0.142 $ 0.142 $ 0.142 $ 0 % 0 % 0 %
common.calendar.number_days.1y 0.3302 $ 0.1321 $ 0.45 $ -57 % 0 % 0 %
common.calendar.number_days.3y 2.53 $ 0.1321 $ 4.01 $ -94.39 % 0 % 0 %
common.calendar.number_days.5y 16.1 $ 0.1321 $ 34.78 $ -99.12 % 0 % 0 %
common.calendar.number_days.10y 0.1321 $ 0.1321 $ 34.78 $ +107.49 % 0 % 0 %
common.calendar.number_days.ytd 0.142 $ 0.142 $ 0.142 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. James R. McCullough M.B.A. Chief Executive Officer 1.04M 1968 (57 années)
Mr. Howard B. Doran Jr. President N/A 1961 (64 année)
Mr. Salim Gulamabbas Hamir F.C.A. Company Secretary N/A
Mr. Joel R. Jung MBA Interim CFO & Principal Accounting Officer 1958 (67 années)

Informations sur l'entreprise

Adresse: United States, New York. NY, 1460 Broadway - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://renalytix.com

À propos de l'entreprise Renalytix Plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.